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SUMMARY – Retinol-binding protein 4 (RBP4) is an emerging risk factor for atherosclerotic 
disease in adults. However, to our knowledge, there are no studies examining the relationship between 
RBP4 and cardiovascular risk in young population. Th erefore, we aimed to estimate this potential 
 relationship in overweight/obese adolescent girls. Seventy overweight/obese adolescent girls, mean 
age 17.6±1.20 years, were included. Anthropometric and biochemical parameters were measured. 
 Cardiovascular risk score (CVRS) was calculated by adding points for each risk factor (e.g., sex, 
high-density lipoprotein cholesterol (HDL-c), non-HDL-c, smoking, blood pressure and fasting 
 glycemia). According to the risk status, we divided adolescent girls into low, medium and high risk 
groups (-2≤ CVRS ≤1, 2≤ CVRS ≤4 and CVRS ≥5, respectively). We found signifi cantly higher RBP4 
in the high risk group as compared with low risk group (p<0.001). However, multiple linear regression 
analysis showed waist circumference (beta=0.257, p=0.031) to be the only independent predictor of 
higher cardiovascular risk (adjusted R2=0.342, p<0.001). In conclusion, RBP4 may be associated with 
higher cardiovascular risk in overweight/obese adolescent girls, but this association is mediated by 
abdominal obesity.
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Introduction
Due to the growing proportion of children and 
adolescents aff ected by obesity, identifying those at an 
increased risk of developing cardiovascular (CV) and 
metabolic complications later in life is of paramount 
importance1. In addition, there is a critical need for 
novel biomarkers to best assess, predict and treat chil-
dren that are prone to develop cardiovascular disease 
(CVD)2. Epidemiological data in Montenegro from 
2008 reported that 21.2% of children and adolescents 
aged 7-19 years were overweight or obese3, whereas in 
2015 the prevalence of childhood overweight and obe-
sity was 22.9% and 5.3%, respectively4.
Obesity is characterized by changes in adipocyto-
kines, activation of low-grade inﬂammation and in-
creased production of reactive oxygen species, leading 
to metabolic disorders, insulin resistance (IR), and 
CVD5,6.
Retinol-binding protein (RBP4) is a recently dis-
covered adipokine that is involved in IR development7. 
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IR was found to be accompanied by down-regulation 
of the insulin responsive glucose transporter-4 
(GLUT4), which might be a signal for RBP4 secre-
tion from adipocytes and development of systemic IR8. 
Moreover, RBP4 has been recently proposed as an 
emerging risk factor of atherosclerotic disease in 
adults9,10.
It is well established that insulin resistance and 
compensatory hyperinsulinemia are the main risk fac-
tors of CVD, eventually leading to plaque formation 
and development of atherosclerosis, through which 
the prominent role of RBP4 as a modulator of athero-
sclerosis in hyperinsulinemia may be explained11.
To our knowledge, there are no studies examining 
the relationship between RBP4 and cardiovascular risk 
in young obese population, having in mind that the 
eff ect of obesity on CVD risk often tracks from child-
hood and adolescence, even if manifest heart disease 
rarely presents before adulthood12. Concerning the 
growing proportion of pediatric population aff ected by 
obesity in Montenegro, we aimed to examine this po-
tential relationship in a cohort of overweight/obese, 
otherwise healthy adolescent girls.
Subjects and Methods
Study population
Th e study included 70 randomly selected over-
weight/obese adolescent girls (mean age 17.6±1.20 
years) who volunteered to participate in the study. Par-
ticipants were selected from several secondary schools 
in Podgorica and were recruited in the Primary Health 
Care Center on their regular check-up in the period 
from December 2012 to March 2013. All the partici-
pants completed a questionnaire including demo-
graphic characteristics, somatic illnesses, medication 
use, and lifestyle habits. Medical history and clinical 
examinations were carried out on the same day. In ad-
dition, all participants with fasting glucose ≥5.6 
mmol/L but ≤6.9 mmol/L underwent a two-hour oral 
glucose tolerance test (OGTT) with 75 g anhydrous 
glucose dissolved in 250 mL of water in order to ex-
clude diabetes13.
Inclusion criteria were overweight and obese, oth-
erwise healthy adolescent girls aged 16-19 years. Girls 
younger than 16 years and older than 19 years, as well 
as girls with diabetes mellitus or fasting glucose ≥7.0 
mmol/L were excluded from the study. Th ere were no 
participants with 2-hour postload glucose ≥11.1 
mmol/L to be excluded from the study13. Furthermore, 
girls with renal dysfunction, hepatic dysfunction, thy-
roid dysfunction, cardiovascular disorders, signs and 
symptoms of acute infl ammatory disease, history of 
alcohol consumption and smoking, and those using 
any medications were also excluded from the study. 
Girls were instructed not to perform any vigorous 
physical activity on the day before the blood was 
drawn. All the participants provided their written in-
formed consent, and for those younger than 18 years 
the parents’ written approval was obtained. Th e study 
protocol was approved by the Ethics Committee of the 
Primary Health Care Center in Podgorica and the re-
search was carried out in compliance with the Decla-
ration of Helsinki14.
Anthropometric measurements
Basic anthropometric measurements including body 
height (cm), body weight (kg) and waist circumference 
(WC, cm) were obtained in the morning. Weight was 
measured to the nearest 0.1 kg on a balance beam 
scale, with the subjects barefoot and with light cloth-
ing. Height was measured to the nearest 0.1 cm using 
a wall-mounted stadiometer, without shoes. WC was 
measured with the non-stretchable tape, over un-
clothed abdomen at the midpoint between the lowest 
rib and the iliac crest, and at the end of normal expira-
tion. Th e tape was parallel to the fl oor and did not 
compress the skin. Body mass index (BMI) was calcu-
lated as weight in kilograms divided by height in 
square meters (kg/m2). BMI z-score was also calculat-
ed. Using the World Health Organization (WHO) 
growth reference 5-19 years15, adolescent girls were 
categorized as overweight (+1SD < BMI z-score 
< +2SD) or obese (with BMI z-score ≥ +2SD). Nor-
mal-weight girls (-2SD ≤ BMI z-score ≤ +1SD) were 
excluded from the study. Blood pressure was measured 
with a sphygmomanometer. Average of three measure-
ments taken on the right arm was recorded. All mea-
surements were taken by the same trained evaluator.
Th e risk of CVD was estimated using modifi ed risk 
score for identifying young individuals with a high 
probability of having advanced atherosclerotic lesions, 
reported by McMahan et al.16. Cardiovascular risk 
score (CVRS) was calculated by adding points for each 
risk factor (e.g., female sex, high-density lipoprotein 
cholesterol (HDL-c), non-HDL-c, smoking, blood 
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pressure and fasting glycemia), as described previous-
ly17. Hypertension was defi ned as systolic blood pres-
sure (SBP) or diastolic blood pressure (DBP) ≥130/85 
mm Hg, and hyperglycemia was defi ned as fasting glu-
cose ≥5.6 mmol/L18.
Biochemical analyses
Blood samples were obtained between 7.00 and 
9.00 a.m., after 12- to 14-hour overnight fast. Samples 
were left to clot for 30 minutes and then centrifuged at 
3000 rpm for 10 minutes. Serum levels of glucose, 
 total cholesterol, HDL-c, low density lipoprotein cho-
lesterol (LDL-c), and triglycerides (TG) were mea-
sured using standardized enzymatic procedures, spec-
trophotometrically (Roche Cobas 400, Mannheim, 
Germany). Serum RBP4 levels were determined using 
a nephelometric assay (Behring Nephelometer Ana-
lyzer, Marburg, Germany). Insulin was measured by 
chemiluminescent immunometric assay (AxSYM, 
Abbott, Abbott Park, IL, USA). Homeostasis model 
assessment of insulin resistance (HOMA-IR) was 
 calculated: HOMA-IR = fasting glucose (mmol/L) x 
fasting insulin (μIU/L)/22.519.
Statistical analysis
Statistical analysis was performed using SPSS statis-
tical package (version 15.0 for Windows, SPSS, Chica-
go, IL, USA). Data are presented as mean ± standard 
deviation, median (interquartile range), or counts and 
percentages. Diff erences between groups were evaluated 
with Student’s t-test for normally and Mann-Whitney 
test for non-normally distributed parameters, or one-
way ANOVA and Kruskal-Wallis nonparametric analy-
sis of variance where appropriate. Spearman’s nonpara-
metric correlation analysis was used to determine the 
relationships between CVRS and other variables. Mul-
tiple linear regression analysis (MLR) was performed to 
identify independent factors aff ecting CVRS and to 
estimate the fi nal predictors of its variability. Due to 
skewed distribution, log transformed HOMA-IR and 
triglycerides were used. In all analyses, p value of <0.05 
was considered statistically signifi cant.
Results
Table 1 shows general clinical and biochemical 
characteristics of the study overweight/obese partici-
pants.
In the current study, we aimed to test the association 
of cardiometabolic parameters with the risk of CVD (as 
estimated using the modifi ed risk score). Th erefore, we 
calculated this cardiovascular risk score (CVRS) for 
 every overweight/obese adolescent girl  included in the 
study and, regarding their risk status level, we divided 
them into low, medium and high risk groups (-2≤ risk 
score ≤1, 2≤ risk score ≤4 and risk score ≥5, respectively). 
We found signifi cant diff erence in several metabolic 
 parameters independent of risk score calculation, i.e., 
signifi cantly higher TG (p<0.001), insulin (p=0.007) 
and HOMA-IR (p=0.001), as well as anthropometric 
parameters (e.g., BMI, BMI z-score and WC) in the 
high risk group as compared with the low risk group 
(p=0.001, p=0.002 and p<0.001, respectively). In addi-
tion, the RBP4 level was found to increase with the 
 increasing cardiovascular risk score (p<0.001). Th ese 
 results are shown in Table 2.
Table 1. General characteristics of overweight/obese 
adolescent girls studied
Characteristic Overweight/obese girls (n=70)
Age (years) 17.6±1.20
BMI (kg/m²) 28.3±3.02
BMI z-score 1.45±0.33
WC (cm) 92.4±12.77
Fasting glucose (mmol/L) 5.18±0.37
Fasting insulin (μIU/L) 8.25 (3.90-12.20)
HOMA-IR 1.89 (0.92-2.87)
TC (mmol/L) 4.27±0.66
HDL-c (mmol/L) 1.39±0.39
LDL-c (mmol/L) 2.45±0.55
TG (mmol/L) 0.88 (0.64-1.23)
Non-HDL-c (mmol/L)
TG/HDL-c ratio 
2.88±0.67
0.63 (0.42-1.10)
SBP (mm Hg) 112±18.1
DBP (mm Hg) 73.4±11.38
RBP4 (mg/L) 33.6±6.65
Cardiovascular risk score 1.00 (-1.00-4.00)
Data are presented as mean ± standard deviation or median (inter-
quartile range); BMI = body mass index; WC = waist circumfer-
ence; HOMA-IR = homeostasis model assessment of insulin resis-
tance; TC = total cholesterol; HDL-c = high density lipoprotein 
cholesterol; LDL-c = low density lipoprotein cholesterol; TG = 
triglycerides; SBP = systolic blood pressure; DBP = diastolic blood 
pressure; RBP4 = retinol-binding protein 4
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Table 2. Cardiometabolic parameters in subgroups according to cardiovascular risk level
Parameter
Low risk score
(-2≤ CVRS ≤1),
n=45
Medium risk score
(2≤ CVRS ≤4),
n=11
High risk score
(CVRS ≥5),
n=14
p*
Age (years) 17.6±1.12 17.4±1.36 17.7±1.38 0.772
BMI (kg/m²) 27.4±2.50aa,bb 30.3±3.42 29.9±3.00 0.001
BMI z-score 1.34±0.27aa,bb 1.65±0.37 1.62±0.36 0.002
WC (cm) 88.4±11.34aa,bb 99.2±11.01 99.9±13.40 <0.001
Glucose (mmol/L) 4.99±0.29aaa,bbb 5.53±0.22 5.49±0.29 <0.001
TC (mmol/L) 4.21±0.63 4.42±0.54 4.35±0.84 0.580
HDL-c (mmol/L) 1.52±0.41aaa,bb 1.18±0.20 1.14±0.18 <0.001
LDL-c (mmol/L) 2.34±0.51 2.62±0.51 2.64±0.65 0.101
TG (mmol/L)# 0.69(0.59-0.92)aa,bb 1.24 (1.03-1.67) 0.99 (0.86-1.39) <0.001
Non-HDL-c (mmol/L)
TG/HDL-c ratio# 
2.69±0.58aa,bb
0.56 (0.32-0.73) aaa,bbb
3.24±0.57
1.14 (0.75-1.44)
3.21±0.78
0.78 (0.72-1.24)
0.005
<0.001
Insulin (μIU//L)# 6.70 (3.67-9.07)aaa 8.30 (3.92-13.60) 12.20 (8.60-19.60) 0.007
HOMA-IR# 1.51 (0.90-2.08)aaa 2.03 (0.95-3.51)aa 3.09 (2.10-5.06) 0.001
SBP (mm Hg) 103±13.1aaa,bbb 122±14.7 132±14.0 <0.001
DBP (mm Hg) 68.5±8.57aaa,b 76.4±10.74a 86.4±8.86 <0.001
RBP4 (mg/L) 31.3±5.71aa,bb 37.8±7.81 37.4±5.36 <0.001
ap<0.05, aap<0.01, aaap<0.001 vs. high risk score; bp<0.05, bbp<0.01, bbbp<0.001 vs. medium risk score; #data with non-gaussian distribution 
are shown as median values (interquartile range); *p value from one-way ANOVA or Kruskal-Wallis nonparametric analysis of variance, 
followed by nonparametric Mann-Whitney U test, where appropriate; CVRS = cardiovascular risk score; BMI = body mass index; WC = 
waist circumference; HOMA-IR = homeostasis model assessment of insulin resistance; TC = total cholesterol; HDL-c = high density 
 lipoprotein cholesterol; LDL-c = low density lipoprotein cholesterol; TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic 
blood pressure; RBP4 = retinol-binding protein 4
Table 3. Spearman’s correlation coeffi  cients (ρ) 
of cardiovascular risk score with study parameters 
independent of risk score calculation in overweight/obese 
adolescent girls
Variable ρ p
Age (years) 0.042 0.727
BMI (kg/m²) 0.422 <0.001
BMI z-score 0.375 0.002
WC (cm) 0.494 <0.001
Insulin (μIU/L) 0.418 <0.001
HOMA-IR 0.471 <0.001
TC (mmol/L) 0.124 0.303
LDL-c (mmol/L) 0.360 0.003
TG (mmol/L) 0.555 <0.001
RBP4 (mg/L) 0.441 <0.001
BMI = body mass index; WC = waist circumference; HOMA-IR = 
homeostasis model assessment of insulin resistance; TC = total 
cholesterol; LDL-c = low density lipoprotein cholesterol; TG = tri-
glycerides; SBP = systolic blood pressure; DBP = diastolic blood 
pressure; RBP4 = retinol-binding protein 4
Table 4. Multiple regression analysis with cardiovascular 
risk score as dependent variable (R²=0.342, p<0.001)
Independent variable B Std. β p
WC 0.070 0.257 0.031
tTG 0.344 0.195 0.124
tHOMA-IR 1.758 0.175 0.132
RBP4 0.079 0.152 0.226
WC = waist circumference; tTG = logarithmically transformed tri-
glycerides; tHOMA-IR = logarithmically transformed homeostasis 
model assessment of insulin resistance; RBP4 = retinol-binding 
protein 4
Th ereafter, we performed Spearman’s nonparamet-
ric correlation to examine the potential relationship 
between cardiovascular risk score and cardiometabolic 
parameters independent of risk score calculation. As 
shown, CVRS correlated positively with BMI z-score 
(p=0.002), BMI and WC (p<0.001 both), LDL-c 
(p=0.003), TG (p<0.001), insulin and HOMA-IR 
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(p<0.001 both), as well as with RBP4 level (p<0.001). 
No signifi cant correlations of CVRS with age and 
 total cholesterol level were observed (Table 3).
Multiple linear regression (MLR) analysis was per-
formed to identify which of the measured markers 
showed highest association with CVRS. Namely, all 
variables found to have a signifi cant predictive value in 
Spearman’s nonparametric correlation (e.g., WC, 
HOMA-IR, TG, RBP4), were further analyzed in 
MLR analysis for CVRS prediction. After MLR, WC 
(beta=0.257; p=0.031) was the only independent pre-
dictor of high cardiovascular risk. Th ese results are 
shown in Table 4. Adjusted R2 for the best model was 
0.342, which means that 34.2% of variation in CVRS 
could be explained with this model.
Discussion
Th e risk of CVD later in life in apparently healthy 
children can be assessed by clustering individual risk 
factors in the same individual, thus describing status 
with several of these risk factors being high at the same 
time20. Obesity is one of the main risk factors associ-
ated with increased CVD risk in children and adoles-
cents17. In the current study, the risk of CVD was esti-
mated using modifi ed risk score, as described previ-
ously17 for identifying young individuals with a high 
probability of having advanced atherosclerotic lesions, 
reported by McMahan et al.16.
We have previously reported on the relationship 
between cardiovascular risk score and several estab-
lished CV risk factors (e.g., ALT activity, hsCRP level, 
TG/HDL-c ratio, and bilirubin concentrations) in the 
group of adolescent girls17. However, there is a critical 
need for research in order to identify more biomarkers 
to best assess, predict and treat children that are prone 
to develop CVD. To our knowledge, the relationship 
between CVRS and RBP4 is a novel fi nding in the 
current study, considering that there are no studies ex-
amining the relationship between RBP4 and cardio-
vascular risk in young population. However, this asso-
ciation is mediated by abdominal obesity as measured 
by WC.
Studies in adult population have shown that RBP4 
is an emerging risk factor of atherosclerotic disease9,10. 
Feng et al.21 showed that RBP4 correlated positively 
with carotid atherosclerosis in patients with type 2 
diabetes mellitus and could be used as an early predic-
tor of CVD. Higher circulating RBP4 concentrations 
were also observed in subjects with high-grade carotid 
stenosis, infl ammatory dilated cardiomyopathy, coro-
nary artery disease and advanced heart failure as com-
pared with control subjects9. Even though RBP4 has 
been proposed as an emerging cardiometabolic risk 
factor in adults10,22, there are discrepancies regarding 
some of the possible metabolic roles of RBP4 in chil-
dren and adolescents23-26.
During 3-year follow up, changes in RBP4 in chil-
dren indicated that increases were associated with 
worsening IR, independently of BMI23. Goodman et 
al.27 provided longitudinal data on the role of RBP4 in 
modulating IR and suggested that the change in IR in 
non-Hispanic black adolescents was related to RBP4 
and was dependent on the initial RBP4 level.
It is well established that IR and compensatory 
 hyperinsulinemia are the main risk factors of CVD11. 
Insulin is a highly potent cell growth factor, which can 
promote vascular smooth muscle cell proliferation, 
thus playing an important role in the development of 
atherosclerosis28. Since RBP4 is related to IR, it has 
been suggested to be involved in the occurrence and 
development of atherosclerosis and CVD11.
On the other hand, other studies did not fi nd sig-
nifi cant diff erences in RBP4 concentrations between 
patients with coronary artery disease and healthy indi-
viduals29,30. In addition, in a prospective six-year study 
in about 1000 patients with CVD, Mallat et al.31 found 
the risk of CVD to have increased with increasing 
RBP4 level. However, after adjustment for confound-
ing factors, positive correlation between the RBP4 
level and the risk of CVD disappeared, thus suggesting 
that RBP4 may not be a good predictor of CVD.
In our study, RBP4 level increased in parallel with 
increasing cardiovascular risk score. However, our re-
sults suggest that the association between RBP4 and 
cardiovascular risk is not independent but that abdom-
inal obesity may be the underlying determinant of this 
relationship. Our results are in line with previous stud-
ies, which suggest that RBP4 is primarily associated 
with adipose tissue mass7.
Limitations of the present study must be consid-
ered. Due to its cross-sectional design, the causal rela-
tionship between biochemical and anthropometric 
parameters and cardiovascular risk could not be estab-
lished. It should also be noted that the small number 
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of participants was a limitation for a study dealing 
with cardiovascular risk assessment. However, the 
fi ndings of the present study supported the hypothesis 
that higher serum RBP4 could in part refl ect a higher 
cardiovascular risk even in young overweight/obese 
population.
Conclusion
High serum RBP4 levels were associated with 
higher cardiovascular risk in overweight/obese adoles-
cent girls, but this association was dependent on ab-
dominal obesity, as measured by WC. Prospective 
studies and further analyses are needed to clarify the 
potential role of RBP4 in adverse cardiovascular out-
comes. Better understanding of its role in CVD risk 
prediction in the adolescent population may lead to 
discovery of a new target therapy for young individuals 
at highest risk of malignant sequels of obesity later in 
life.
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Sažetak
POVEZANOST RETINOL-VEZUJUĆEG PROTEINA 4 I KARDIOVASKULARNOG RIZIKA 
POSREDOVANA JE OBIMOM STRUKA KOD PRETILIH/DEBELIH ADOLESCENTICA
A. Klisić, N. Kavarić, B. Bjelaković, I. Soldatović, M. Martinović i J. Kotur-Stevuljević
Retinol-vezujući protein 4 (RBP4) je novi čimbenik rizika za aterosklerotsku bolest kod odraslih. Međutim, prema 
 našem saznanju nema studija koje su ispitivale povezanost između RBP4 i kardiovaskularnog rizika u mlađoj populaciji. Zato 
je cilj naše studije bio ispitati ovu moguću povezanost kod pretilih/debelih adolescentica. U istraživanju je sudjelovalo  ukupno 
70 pretilih/debelih adolescentica u dobi od 17,6±1,20 godina. Mjereni su antropometrijski i biokemijski parametri. Zbir 
kardiovaskularnog rizika (engl. cardiovascular risk score, CVRS) računao se dodavanjem bodova za svaki pojedinačni čimbenik 
rizika (npr. spol, HDL-c ne-HDL-c, pušenje, krvni tlak i glikemija natašte). Prema stupnju kardiovaskularnog rizika ado-
lescentice smo podijelili u tri skupine s niskim, srednjim i većim rizikom (-2≤CVRS≤1, 2≤CVRS≤4, i CVRS ≥5). Uočili smo 
statistički značajno višu razinu RBP4 u skupini s većim rizikom u usporedbi sa skupinom s niskim rizikom (p<0,001). 
 Međutim, primjenom multiple regresijske analize uočili smo da je obim struka (beta=0,257, p=0,031) jedini nezavisni 
 predskazatelj većeg kardiovaskularnog rizika (R2=0,342, p<0,001). U zaključku, RBP4 može biti povezan s većim kardiova-
skularnim rizikom kod pretilih/debelih adolescentica, ali je ova povezanost posredovana abdominalnom pretilošću.
Ključne riječi: Adolescenti; Kardiovaskularne bolesti; Rizik; Pretilost; Retinol-vezujući protein 4
